Plasma Small Extracellular Vesicle Cardiac miRNA Expression in Patients with Ischemic Heart Failure, Randomized to Percutaneous Intramyocardial Treatment of Adipose Derived Stem Cells or Placebo: Subanalysis of the SCIENCE Study.
adipose-derived stem cells
extracellular vesicles
ischemic heart disease
microRNA
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
26 Jun 2023
26 Jun 2023
Historique:
received:
22
05
2023
revised:
20
06
2023
accepted:
23
06
2023
medline:
17
7
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
Small extracellular vesicles (EVs) and their cargo are an important component of cell-to-cell communication in cardiac disease. Allogeneic adipose derived stem cells (ADSCs) are thought to be a potential approach for cardiac regenerative therapy in ischemic heart disease. The SCIENCE study investigated the effect of ADSCs administered via intramyocardial injection on cardiac function in patients with ischemic heart disease. The aim of this substudy, based on samples from 15 patients, was to explore small EV miRNA dynamics after treatment with ADSCs compared to a placebo. Small EVs were isolated at several timepoints after the percutaneous intramyocardial application of ADSCs. No significant effect of ADSC treatment on small EV concentration was detected. After 12 months, the expression of miR-126 decreased significantly in ADSC patients, but not in the placebo-treated group. However, all cardiac miRNAs correlated with plasma cardiac biomarkers. In line with the overall negative results of the SCIENCE study, with the exception of one miR, we did not detect any significant regulation of small EV miRNAs in this patient collective.
Identifiants
pubmed: 37445825
pii: ijms241310647
doi: 10.3390/ijms241310647
pmc: PMC10342130
pii:
doi:
Substances chimiques
MicroRNAs
0
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Österreichischer Herzfonds
ID : 201902
Organisme : European Commission
ID : 6434
Références
Nat Rev Cardiol. 2011 May 17;8(7):393-404
pubmed: 21587214
Cells. 2022 Apr 19;11(9):
pubmed: 35563681
Cardiology. 2011;118(4):217-26
pubmed: 21701171
Nat Cell Biol. 2011 Apr;13(4):423-33
pubmed: 21423178
J Clin Invest. 2014 May;124(5):2136-46
pubmed: 24743145
Cell Death Dis. 2018 Feb 23;9(3):320
pubmed: 29476052
ESC Heart Fail. 2022 Apr;9(2):1152-1159
pubmed: 35043578
J Clin Invest. 2019 Apr 29;129(6):2237-2250
pubmed: 31033484
J Exp Med. 2011 Mar 14;208(3):549-60
pubmed: 21383058
Cells. 2020 Mar 02;9(3):
pubmed: 32131460
Theranostics. 2020 Jan 1;10(3):1060-1073
pubmed: 31938051
Int J Mol Sci. 2022 Jul 06;23(14):
pubmed: 35886860
Kaohsiung J Med Sci. 2018 Nov;34(11):626-633
pubmed: 30392569
Cell Commun Signal. 2021 Oct 16;19(1):104
pubmed: 34656117
Stem Cell Res. 2010 May;4(3):214-22
pubmed: 20138817
N Engl J Med. 2021 Nov 4;385(19):1737-1749
pubmed: 34554658
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5003-8
pubmed: 21383194
J Cell Mol Med. 2009 Apr;13(4):778-89
pubmed: 19320780
Circulation. 2011 Aug 9;124(6):720-30
pubmed: 21788589
J Extracell Vesicles. 2013 Dec 23;2:
pubmed: 24376909
Am Heart J. 2007 Feb;153(2):212.e1-7
pubmed: 17239678
J Cell Mol Med. 2012 Sep;16(9):2150-60
pubmed: 22260784
Nat Rev Mol Cell Biol. 2020 Oct;21(10):585-606
pubmed: 32457507
Mol Ther Nucleic Acids. 2020 Jun 5;20:649-660
pubmed: 32380415
Heart. 2007 Jul;93(7):837-41
pubmed: 17309910
Front Physiol. 2020 Jun 11;11:654
pubmed: 32595526
Front Cell Dev Biol. 2020 Apr 17;8:236
pubmed: 32363193
Int J Cardiol. 2018 Dec 15;273:230-236
pubmed: 30297190
Cardiovasc Res. 2011 Sep 1;91(4):649-58
pubmed: 21498423
World J Stem Cells. 2021 Nov 26;13(11):1747-1761
pubmed: 34909121
Eur Heart J. 2020 Sep 21;41(36):3451-3458
pubmed: 32749459
Biomed Pharmacother. 2019 Jun;114:108765
pubmed: 30921703
Eur J Cell Biol. 2022 Jun-Aug;101(3):151226
pubmed: 35460959
Apoptosis. 2016 Dec;21(12):1336-1353
pubmed: 27696124
Methods Mol Biol. 2014;1182:289-305
pubmed: 25055920
Pharmacol Res. 2018 Jan;127:92-100
pubmed: 28554583
PLoS One. 2021 Jan 26;16(1):e0246083
pubmed: 33497386
Front Cardiovasc Med. 2022 Jul 29;9:943068
pubmed: 35966562
Eur J Heart Fail. 2019 Aug;21(8):1032-1041
pubmed: 30790396
Circ Cardiovasc Genet. 2010 Dec;3(6):499-506
pubmed: 20921333
Eur J Heart Fail. 2023 Apr;25(4):576-587
pubmed: 36644821
Nat Rev Cardiol. 2014 Apr;11(4):232-46
pubmed: 24594893
Dev Cell. 2008 Aug;15(2):272-84
pubmed: 18694566
Stem Cells Transl Med. 2018 Apr;7(4):354-359
pubmed: 29468830
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Front Physiol. 2018 Apr 05;9:348
pubmed: 29674977
Circ Res. 2017 Nov 10;121(11):1279-1290
pubmed: 28923793
J Am Coll Cardiol. 2014 Jun 3;63(21):2177-87
pubmed: 24583309
PLoS One. 2008;3(11):e3694
pubmed: 19002258
Biomed Res Int. 2018 Jan 30;2018:8545347
pubmed: 29662902
Cell Tissue Res. 2022 Oct;390(1):71-92
pubmed: 35788900
Cardiovasc Pathol. 2015 Jul-Aug;24(4):199-206
pubmed: 25958013
J Intern Med. 2014 Dec;276(6):633-44
pubmed: 25160930